Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity

Published:2002-01 Issue:1 Volume:4 Page:49-55
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Gokcel A.,Gumurdulu Y.,Karakose H.,Melek Ertorer E.,Tanaci N.,Bascil Tutuncu N.,Guvener N.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1463-1326.2002.00181.x/fullpdf

Reference37 articles.

1. The health consequences of moderate obesity;Larsson;Int J Obes Relat Metab Disord,1981

2. Obesity and cardiovascular disease;Rexrode;Curr Opin Cardiol,1996

3. Longitudinal studies to determine the effect of body fat rate reduction on blood pressure;Wada;J Med Syst,1998

4. Epidemiology and natural history of gallstone disease;Diehl;Gastroenterol Clin N Am,1991

5. Obesity, levels of lipids and glucose, and smoking among Navajo adolescents;Freedman;J Nutr,1997

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials;Diabetes, Obesity and Metabolism;2024-03-11

2. Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis;Irish Journal of Medical Science (1971 -);2023-05-06

3. Mechanisms of ageing: growth hormone, dietary restriction, and metformin;The Lancet Diabetes & Endocrinology;2023-04

4. Metformin Treatment Leads to Increased HIV Transcription and Gene Expression through Increased CREB Phosphorylation and Recruitment to the HIV LTR Promoter;Aging and disease;2023

5. Therapeutic and Adverse Effects of Metformin in Diabetes: A Review Article;International Journal of Life Science and Pharma Research;2022-12-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3